Sepsis: The evolution in definition, pathophysiology, and management

B Gyawali, K Ramakrishna… - SAGE open …, 2019 - journals.sagepub.com
There has been a significant evolution in the definition and management of sepsis over the
last three decades. This is driven in part due to the advances made in our understanding of …

[HTML][HTML] Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

ML Schubert, M Schmitt, L Wang, CA Ramos… - Annals of oncology, 2021 - Elsevier
Highlights•CAR T cells are associated with unique side-effects.•Cytokine release syndrome
(CRS), immune effector cell-associated neurotoxicity syndrome (ICANS) and cytopenias are …

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

L Evans, A Rhodes, W Alhazzani, M Antonelli… - Critical care …, 2021 - journals.lww.com
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …

[PDF][PDF] Living guidance for clinical management of COVID-19: living guidance, 23 November 2021

World Health Organization - 2021 - apps.who.int
This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

[PDF][PDF] COVID-19 clinical management: living guidance, 25 January 2021

(‎ 2021 World Health Organization - 2021 - apps.who.int
The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021

L Evans, A Rhodes, W Alhazzani, M Antonelli… - Critical care …, 2021 - journals.lww.com
Surviving Sepsis Campaign: International... : Critical Care Medicine Executive Summary:
Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic …

[PDF][PDF] Clinical management of COVID-19: interim guidance, 27 May 2020

(2020 World Health Organization - 2020 - apps.who.int
Methods The original version of this document was developed in consultation with the
International Forum for Acute Care Trialists (InFACT), International Severe Acute Respiratory …

[PDF][PDF] Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020

World Health Organization - 2020 - apps.who.int
This is the first edition of this document for novel coronavirus, an adaption of WHO Clinical
management of severe acute respiratory infection when MERS-CoV infection is suspected …

[PDF][PDF] Clinical management of COVID-19: living guideline, 13 January 2023

World Health Organization - 2023 - apps.who.int
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-
CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at …

[PDF][PDF] Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020

(‎ 2020 World Health Organization - 2020 - apps.who.int
Background Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by
a newly emergent coronavirus, that was first recognized in Wuhan, China, in December …